Explore the latest oncology biotech news, from clinical data to fundraising and biotech deals, in our September 2026 roundup.
At NLS Days 2026, life science companies and a record number of investors attended to showcase data, partner, and raise ...
Delve into the AstraZeneca pipeline strategy in 2026 as its oncology franchise keeps growing and it invests in diversification.
Find out what came out of the World Conference on Lung Cancer (WCLC) 2026, from late-stage successes and failures to earlier-stage promise.
Discover how GLP-1 drugs are being studied for potential new indications, from autoimmune diseases and addiction to Parkinson’s and MASH.
A lot is going on in the GLP-1 space in 2026, a market that landed $79 billion last year, and could shift significantly in the coming years.
Meet Spain's biotech ecosystem at BIOSPAIN 2026 in Bilbao. Now annual, the event draws 1,000+ companies and participants from 30+ countries.
China’s biotech scene has evolved significantly over the last few years, with companies increasingly developing novel drugs and attracting international attention through partnerships and ...
Results that may be inaccessible to you are currently showing.
Hide inaccessible results